phcl 554 cardiovascular pharmacology douglas larson, ph.d. 626-0944 [email protected]

55
PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 [email protected]

Upload: kerry-owen

Post on 18-Jan-2016

217 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

PHCL 554

Cardiovascular Pharmacology

Douglas Larson, Ph.D.626-0944

[email protected]

Page 2: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Course Format

• Mondays – basic concepts

• Wednesdays – applied concepts

• Fridays – problem based learning

• Exams – 50% multiple choice and 50% essay

• Final – NIH grant take-home grant

Page 3: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiovascular Physiology

Introduction:

•The Heart

•Anatomy

•Cardiac output

•Effectors of cardiac output

Page 4: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiovascular Physiology

No understanding of the circulatory reactions of the body is possible unless we start first with the fundamental properties of the heart muscle itself, and then find out how these are modified, protected, and controlled under the influence of the mechanisms - nervous, chemical, and mechanical - which under normal conditions play on the heart and blood vessels. E.H. Starling, 1920

Page 5: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiovascular Physiology

•The heart pumps blood through two vascular systems - the low pressure pulmonary circulation in which gas exchange occurs, and then the systemic circulation, which delivers blood to individual organs, matching supply to metabolic demand.

•Blood pressure and flow is largely controlled by the autonomic nervous system.

Page 6: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiovascular Physiology

•The heart comprises four chambers, and is divided into a right and left side, each with an atrium and a ventricle.

• The chambers are separated by four valves.

Page 7: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 8: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiovascular Physiology

• What is the physiologic function of the atria?

• What is the physiologic function of the valves?

Page 9: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiovascular Physiology

Answers

• What is the physiologic function of the atria? Continuous inflow

• What is the physiologic function of the valves? Provides direction to blood flow

Page 10: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 11: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 12: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 13: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 14: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 15: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 16: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 17: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 18: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 19: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 20: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 21: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 22: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Coronary Arteries

Page 23: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 24: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Myocardium transverse section

Page 25: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Intercalated Disks (ID)

Page 26: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Intercalated Disks (ID)

• Functionally the ID acts as a communication site and a point of adherence between two myocytes. The ID is a site of lowered electrical resistance.

• Gap junctions running between the two myocytes take care of the communication. The passage of ions through the gap junctions into the intercellular space keeps adjacent cells "informed" about what's happening.

Page 27: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Intercalated Disks

• The coordination of the heartbeat and the transmission of the contraction signal from one cell to the next is dependent on the integrity and proper functioning of the ID's gap junctions.

• Cell-to-cell adherence is maintained here (as at other sites) by numerous desmosomes. These are scattered along the length of the ID.

Page 28: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Gap Junction

Page 29: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiac Myocyte

Page 30: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiac Myocyte

Two myocytes connected by ID

Page 31: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Myofibrils

• A band (anisotropic) myosin – actin filament overlap

• I band (Isotropic) contain only actin filaments

• H band (helle) only myosin

• M band are cross filaments that hold myosin

• Z line (Z disk) is junction of sarcomere

Page 32: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

A M & H

Z

I

Page 33: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 34: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Cardiac

Myocyte

Page 35: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 36: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Autonomic nerves and the heart

Page 37: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Autonomic nerves & heart• Sympathetic

–These nerves arise mainly from the stellate ganglion below the head of the first rib

– Innervates both atria and ventricles and release norepinephrine

–Change heart rate, systolic and diastolic function

• Parasympathetic

–Cardiac branches of the vagus nerve

– Innervate mainly atria and release ACH

–Confined to changes in heart rate

Page 38: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Question

Parasympathetic stimulation of the hearta. Increases heart rateb. Decreases heart ratec. Increases contractilityd. Uses norepinephrine as a

neurotransmitter

Page 39: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

ELECTROPHYSIOLOGY OF THE HEART

• Myocardial contraction results from a change in voltage across the cell membrane (depolarisation), which leads to an action potential.

• Although contraction may happen spontaneously, it is normally in response to an electrical impulse. This impulse starts in the sinoatrial (SA) node, a collection of pacemaker cells located at the junction of the right atrium and superior vena cava.

Page 40: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

ELECTROPHYSIOLOGY OF THE HEART

• These specialised cells depolarise spontaneously, and cause a wave of contraction to pass across the atria.

• Following atrial contraction, the impulse is delayed at the atrioventricular (AV) node, located in the septal wall of the right atrium.

• From here His-Purkinje fibres allow rapid conduction of the electrical impulse via right and left branches, causing almost simultaneous depolarisation of both ventricles.

Page 41: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

ELECTROPHYSIOLOGY OF THE HEART

Page 42: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

ELECTROPHYSIOLOGY OF THE HEART

Page 43: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Action Potential

Page 44: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Question

The ion responsible for the rapid depolarization of the cardiac myocyte is:a. Norepinephrineb. Ca++

c. Na+

d. K+

Page 45: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

ATP NaHX

3N2

Na2K

Ca++

Ca++L-typeCa++ Channel

ICa

Ca++ Ca++

Myofibril

SRCa -ATPase++Phospholamban

Ca++Calseq

Sarcoplasmic Reticulum

RyanodineReceptor

Ca++

3Na

H

T-TubuleNa

CaXATP

3Na+

Calcium Cycling Proteins

Page 46: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

CardiacCycle

Page 47: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Factors influencing cardiac performance

• Resting muscle fiber length (preload or end-diastolic pressure/volume) Starling's Law.

• Degree of after loading (pulmonary artery pressure, mean arterial pressure)

• Inotropic state (contractility): drugs and hormones can profoundly affect cardiac performance through this mechanism.

• Frequency of contraction (increased heart rate is a postive inotropic stimulus) .

Page 48: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Starling’s Law

• Starling's law of the heart, which states that the energy of contraction of the muscle is related/proportional to the initial length of the muscle fiber.

Page 49: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Preload

Page 50: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Afterload

Page 51: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Definitions•Inotropic = increased force and

rate of contraction

•Lustitropic = increased rate of relaxation

•Chronotropic = increased heart rate

Page 52: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Questions?

Page 53: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu

Notes and Powerpoints

WEB Site: http://perfusion.arizona.edu

PHCL 554

Username: phcl554

Password: s06ua554

Page 54: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu
Page 55: PHCL 554 Cardiovascular Pharmacology Douglas Larson, Ph.D. 626-0944 dflarson@u.arizona.edu